ValueMAxess Ltd
Business Coaches
ValueMAxess Ltd
Bentinck House, London
# ValueMAxess Ltd
ValueMAxess Ltd is a specialist Market Access and Interim Management consultancy headquartered in London with offices across Germany, Norway and additional European coverage through partner agencies. Founded in 2010 by Andreas Guhl, a veteran of the pharmaceutical and medical device sectors with over 20 years' experience at major organisations including Allergan, Lilly, BIOGEN and Medtronic, the firm has established itself as one of Europe's longest-established independent Market Access consultancies.
The company primarily serves pharmaceutical and medical device manufacturers navigating complex European healthcare markets, particularly Germany's AMNOG (early benefit assessment) process. ValueMAxess guides clients through the entire AMNOG pathway—from clinical trial design strategy and GKV-Spitzenverband price negotiations to arbitration proceedings and dossier preparation. This expertise extends to France, Italy, Austria, Switzerland, Scandinavia and Spain through established partnerships.
What distinguishes ValueMAxess is its proprietor-led model emphasising quality outcomes over overhead costs. Rather than charging for internal infrastructure, the firm delivers expert services at competitive fees, having successfully supported international companies without German branch offices. The founder's credentials are exceptional: co-founder of the European Journal of Health Economics with former German Health Minister Professor Karl Lauterbach, regular conference speaker, and advisory board member to pharmaceutical organisations. The team offers both independent project delivery and on-site interim management to cover staffing gaps, illness absences or temporary workload surges.
ValueMAxess Ltd is a specialist Market Access and Interim Management consultancy headquartered in London with offices across Germany, Norway and additional European coverage through partner agencies. Founded in 2010 by Andreas Guhl, a veteran of the pharmaceutical and medical device sectors with over 20 years' experience at major organisations including Allergan, Lilly, BIOGEN and Medtronic, the firm has established itself as one of Europe's longest-established independent Market Access consultancies.
The company primarily serves pharmaceutical and medical device manufacturers navigating complex European healthcare markets, particularly Germany's AMNOG (early benefit assessment) process. ValueMAxess guides clients through the entire AMNOG pathway—from clinical trial design strategy and GKV-Spitzenverband price negotiations to arbitration proceedings and dossier preparation. This expertise extends to France, Italy, Austria, Switzerland, Scandinavia and Spain through established partnerships.
What distinguishes ValueMAxess is its proprietor-led model emphasising quality outcomes over overhead costs. Rather than charging for internal infrastructure, the firm delivers expert services at competitive fees, having successfully supported international companies without German branch offices. The founder's credentials are exceptional: co-founder of the European Journal of Health Economics with former German Health Minister Professor Karl Lauterbach, regular conference speaker, and advisory board member to pharmaceutical organisations. The team offers both independent project delivery and on-site interim management to cover staffing gaps, illness absences or temporary workload surges.
Services offered
AMNOG process supportPrice negotiationsClinical trial design strategyMarket Access interim managementHealthcare system trainingAdvisory board organisationCost-effectiveness claimsMarket Access marketing and communication